Study Links Asbestos Exposure from Residential Insulation to Cancer Risks

Background on Asbestos Use

A recent study conducted in Australia explored the connection between asbestos exposure from residential insulation and the risk of developing cancers, particularly mesothelioma. Until the 1990s, asbestos-containing materials were widely used as insulation in homes across Australia, Canada, and the United States. There is considerable evidence linking asbestos to mesothelioma and other cancers, including lung, ovarian, and laryngeal cancers. This evidence primarily stems from studies of individuals exposed in occupational settings, such as miners, construction workers, and their families, as well as those living near asbestos-related industries. However, the relationship between residential asbestos exposure and cancer risk remains less understood.

Investigating the Cancer Risk in Residential Settings

To assess the link between mesothelioma and other cancers and living in homes with loose-fill asbestos insulation, Korda and colleagues conducted a cohort study in the Australian Capital Territory (ACT). Their findings were published in The Lancet Public Health. The study included participants enrolled in the Australian universal health insurance system from November 1, 1983, to December 31, 2013.

Participants were categorized as either exposed (those who resided in properties with asbestos insulation during the study period) or unexposed (those who never lived in an asbestos-affected property). The study focused on the development of various cancers, including mesothelioma, lung cancer (including bronchus, lung, and trachea), ovarian cancer, laryngeal cancer, pharyngeal cancer, stomach cancer, and colorectal cancer. Additionally, four common cancers with limited association to asbestos—bladder cancer, kidney cancer, melanoma, and prostate cancer—were also analyzed.

Study Findings

Throughout the study, 1,035,578 individuals who had ever lived in the ACT were identified, with 17,248 classified as exposed due to their residency in affected properties. A total of 285 individuals (all men) were diagnosed with mesothelioma, seven of whom had previously lived in an asbestos-affected home.

Mesothelioma Rates in Exposed vs. Unexposed Individuals

The analysis revealed that the incidence of mesothelioma among unexposed males was 2.25 cases per 100,000, while for exposed males, the rate was 8.26 cases per 100,000. This indicates a 2.5-fold increase in mesothelioma risk for those exposed. Conversely, no significant association was found between asbestos exposure and the risk of lung, ovarian, laryngeal, pharyngeal, or stomach cancers. However, an increase in colorectal cancer rates was observed in both males and females who had lived in affected properties, although the increase in males was not statistically significant. For bladder and kidney cancers, no notable differences were detected between the exposed and unexposed groups. Nevertheless, prostate cancer rates were found to be higher in exposed men compared to their unexposed counterparts.

Conclusions and Implications

This study represents the first comprehensive evaluation of the cancer risks associated with living in homes insulated with asbestos. The findings suggest that asbestos exposure in residential settings can elevate the risk of mesothelioma, colorectal cancer, and prostate cancer. Despite its effectiveness as an insulator, asbestos poses significant health risks in both occupational and residential environments. Therefore, it is crucial for governments to consider the health, legal, and social ramifications of using such materials in homes.

Reference

Korda RJ, Clements MS, Armstrong BK, Law HD, Guiver T, Anderson PR, Trevenar SM, Kirk MD. Risk of cancer associated with residential exposure to asbestos insulation: a whole-population cohort study. Lancet Public Health 2017; 2: e522–28.

Disclaimer

The article includes sponsored links to external sites for informational purposes. The editorial team of the Medical News Bulletin did not influence the content of these linked sites and bears no responsibility for their accuracy or content. The views expressed in the sponsored links reflect those of the advertisers and do not represent the Medical News Bulletin’s stance. The Bulletin does not accept liability for any losses or damages resulting from the use of any products or services mentioned in these sponsored links.